Sudden cardiac death is a major world-wide public health burden with an estimated annual incidence ranging from 180,000 to 450,000 1 in the United States (US) and as much as 3.7 million deaths word-wide 2 . Pediatric sudden cardiac arrest (SCA) has a devastating and profound societal impact. Approximately 3000 infants die suddenly and unexpectedly each year before reaching one year of age and another 2000-5000 young people between 1 and 35 years die following SCA yearly 3 . Those who survive a SCA are often left with neurological sequelae 4 .
Long QT Syndrome (LQTS), with an estimated prevalence of 1:2500, is a major and often preventable cause of SCA in the young 5 . LQTS, characterized by delayed ventricular cardiomyoctye repolarization and cardiac action potential prolongation that may present as a prolonged QT-interval on a 12-lead surface electrocardiogram 6 , may manifest as syncope, seizures, or SCA typically following a precipitating event such as exertion, extreme emotion, auditory stimuli, or even at rest. Identifying and understanding the genetic etiology can have a profound life-saving impact on the overall clinical management and prophylactic treatment of an LQTS patient 7 .
LQTS is most often inherited as an autosomal dominant trait; however sporadic and autosomal recessive inheritance patterns have been reported 7 . LQTS is characterized as a cardiac channelopathy with the majority of cases due to mutations within three genes (KCNQ1, KCNH2, and SCN5A) that encode for critical ion channel alpha-subunits responsible for the cardiac action potential. However, ~20% of patients with clinically definite LQTS remain genetically elusive 7 .
In this study, we performed whole exome sequencing (WES) to identify a novel genetic explanation for a LQTS pedigree with a presumed sporadic/autosomal recessive inheritance pattern and a subsequent mutational analysis of the novel candidate gene on an additional cohort of unrelated, genetically elusive LQTS patients. Collectively, the phenotype for this novel, prolonged QT-interval on a 12-lead surface electrocardiogram 6 , may manifest as sy sy sync nc ncop op ope, e, e, eizures, or SCA typically following a precipitating event such as exertion, extreme emotion, audi ito to tory ry ry s s sti ti timu m m li, , , or or or even at rest. Identifying and d un un unde d d rstanding the gene e eti ti tic etiology can have a p p prof f found life-sa a av v ving ng g i i imp mp mpac ac act t t on on on t t the he he o o ove ve era all c c clin ni n ca al m m mana na nage ge geme me ment nt t a a and nd nd p p pro ro rop phyl lac ac acti ti tic c c tr tr trea e e tm tm tmen n nt t t of of of a a an t t LQ LQ QTS TS TS patie ent nt nt 7 .
LQ LQ LQTS TS TS i i is s s mo mo most st st o o oft ft ften en en i i inh nh nher er erit it ited ed ed a a as s s an an an a a aut t uto o oso so soma ma mal l l do do domi mi mina na nant nt nt t t tra ra rait it it; ; ; ho ho howe e weve e ver r r sp sp spor or orad ad adic ic ic a a and nd nd potentially lethal syndrome, termed triadin knockout (TKO) syndrome, is detailed.
Methods

Sporadic/Autosomal Recessive LQTS Pedigree
An African American family with presumed sporadic or autosomal recessive LQTS was referred to the Mayo Clinic Windland Smith Rice Sudden Death Genomics Laboratory for further research-based genetic testing following negative commercially available genetic testing for LQTS. The index case was a 10-year-old female who first experienced syncope at 1 year of age while riding her tricycle, and then again at 2 years of age while dancing. Both parents were considered unaffected with normal ECGs and a negative personal and family history for cardiac related events. Following written informed consent for this Mayo Clinic IRB approved study;
blood was collected for all three family members and genomic DNA was isolated.
Whole Exome Sequencing (WES)
WES and subsequent variant annotation was performed on genomic DNA derived from the symptomatic index case, unaffected father, and unaffected mother by the Mayo Clinic Advanced
Genomics Technology Center and Bioinformatics Core facilities. Paired-end libraries were prepared following the manufacturer's protocol (Agilent) using the Bravo liquid handler from Agilent. Briefly, 1-3 ug of genomic DNA was fragmented to 150-200 bp using the Covaris E210
sonicator. The ends were repaired and an "A" base was added to the 3' ends. Paired end Index DNA adaptors (Agilent) with a single "T" base overhang at the 3' end were ligated and the resulting constructs were purified using AMPure SPRI beads (Agencourt). The adapter-modified DNA fragments were enriched by 4 cycles of PCR using SureSelect forward and SureSelect ILM Pre-Capture Indexing reverse (Agilent) primers. The concentration and size distribution of the considered unaffected with normal ECGs and a negative personal and family histo to tory ry ry f f for or or c c car ar ardi di dia a ac elated events. Following written informed consent for this Mayo Clinic IRB approved study;
bloo o od d d wa wa was s s co co collec c cte te ted for all three family members rs rs a a and n n genomic DNA w w was as as isolated. y
Wh Wh Whole Exome S S Sequ qu ue e enci ci cing ng ng ( ( (WE WE WES) S) S)
WE WE WES S S and su u ubs b b eue e ent v v va ar a iant nt t a a ann n n ot t tat at a io o on wa as s s Whole exon capture was carried out using the protocol for Agilent's Sure SelectXT Human All Exon V5+UTR kit. Briefly, 750 ng of the prepped library was incubated with whole exon biotinylated RNA capture baits supplied in the kit for 24 hours at 65 °C. The captured DNA:RNA hybrids were recovered using Dynabeads MyOne Streptavidin T1 (Dynal). The DNA was eluted from the beads and purified using Ampure XP beads (Agencourt). The purified capture products were then amplified using the SureSelect Post-Capture Indexing forward and Index PCR reverse primers (Agilent) for 12 cycles.
Libraries were pooled at equimolar concentrations and loaded onto paired end flow cells at concentrations of 7-8 pM to generate cluster densities of 600,000-800,000/mm 2 following
Illumina's standard protocol using the Illumina cBot and HiSeq Paired end cluster kit version 3.
Each lane of a HiSeq flow cell produced 21-39 Gbases of sequence. The level of sample pooling was controlled by the size of the capture region and the desired depth of coverage.
The flow cells were sequenced as 101 X 2 paired end reads on an Illumina HiSeq 2000 using TruSeq SBS sequencing kit version 3 and HiSeq data collection version 2.0.12.0 software.
Base-calling was performed using Illumina's RTA version 1.17.21.3.
The Illumina paired end reads were aligned to the hg19 reference genome using Novoalign (http://novocraft.com) followed by the sorting and marking of duplicate reads with Picard (http://picard.sourceforge.net). Local realignment of INDELs and base quality score recalibration were then performed using the Genome Analysis Toolkit (GATK) 8 . Single nucleotide variants (SNVs) and insertions/deletions (INDELs) were called across all of the samples simultaneously using GATK's UnifiedGenotyper with variant quality score recalibration 9 .
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Following WES, single nucleotide variants (SNVs) and insertion/deletions (INDELs) were filtered to identify variants which followed either a sporadic or recessive inheritance pattern using Ingenuity Variant Software (Qiagen, Redwood City, CA). All variants were first filtered for a call quality score 20 and present in genes outside the top 1% of genes with high variability. To be considered a candidate mutation, the variant identified in the child had to be and ToppGene ( www.toppgene.cchmc.org ). The 3 most prevalent LQTS-causing genes (KCNQ1, KCNH2, and SCN5A) were used to train these algorithms. Gene priority ranking was performed using default settings for each tool. The gene priority ranking from each tool was combined and a final composite ranking was created.
DNA Sanger Sequencing for Variant Confirmation
Standard DNA dye terminator cycle sequencing protocols and an ABI Prism 377 automated Opportunity [NHLBI GO ESP] Exome Sequencing Project [n=6503 subjects; 4300 00 00 C C Cau au auca ca casi si sian an ans s s and 2203 African-Americans] 11 databases) that were absent in the exomes of both parents were cons s sid id ider er ered ed ed. . . Fo F F r th th the e e recessive inheritance model, , , on on only l rare (allele freque e en n ncy 1% in the 1KG, an an and d d the NHLBI I I G GO GO E E ESP P P d d da a atab ab aba as ase e es) ) ) va a ari iants ts ts p p presen en nt as s s e e eit it ithe he her r r ho ho h mo mo mozy zy zyg g got tes (s (s (sam am ame e e m m muta ta tat t tion on on n n nhe he heri ri r ted from om om eac ac ach h pa a are e ent) o o or c c com m mpo p p u u und d d he e ete e ero r zy y yg g gote e es ( (tw w wo un un u i i ique ue ue mut u utatio o ons ns ns in th th the e e sa am m me gen e ene ea ea each ch ch i i inh nh nher er erit it ited ed ed f f fro ro rom m m a a a di di diff ff ffer er eren en ent t t pa pa pare re rent nt nt) ) ) we e were re re c c con on onsi si side de dere re red d d. when comparing the overall yield of TRDN mutations in patients that are 10 years of age to the yield observed in patients that are > 10 years of age. This analysis was performed for the discovery subject (n=1) plus the unrelated subjects (n=33).
Comprehensive mutational analysis of all 8 coding region exons of the TR R RDN DN DN g g gen en ene e e N N N NM_001256021.1) that encodes the cardiac-specific isoform triadin (also known as Trisk 32, NP_0 _0 _001 01 0124 24 2429 29 2950) ) ) w w was performed on genomic DN N NA A A fr f f om these 33 LQTS S S p p patients using PCR, DH DH DHPL P C, and d D D DNA N NA S S San an a ge ge ger r r Se Se Sequ qu quen en enci ci cing g g. Only ly ly r rare e e n n non-s -s -sy yn ynon on onym ym ymou ou ous s ho ho homo mo m zy y ygo go gous us us o o or r r co o omp mp mpou ou ound nd nd he e ete te tero ro rozygous us us mu ut u a at a ions ns ns with h h a a a he h h te e er r roz z zyg go g te e e f f fr r requ uen n ncy y y o o of 1 1 1% % % i i in the he h 1 1 1K KG 1 10 1 a a and t t the he he NHL HL LBI G GO ES ES ESP P P 11 11 wer er ere e e co co cons ns nsid id ider er ered ed ed t t to o o be be be p p pat at atho ho hoge ge geni ni nic c c. Although her LQTS diagnostic score 12 was 7 consistent with high probability LQTS, her stress test was atypical for LQTS with ventricular ectopy during the stress test and throughout the recovery phase until her heart rate was < 85 beats per minute. Although her T-wave inversions satisfied one of the 2010 task force minor criteria for arrhythmogenic right ventricular cardiomyopathy (ARVC, alternatively referred to as arrhythmogenic cardiomyopathy or ACM), she does not exhibit any major task force criteria for a clinical diagnosis of ARVC/ACM. Alth h hou ou ough h h h h her L L LQ QT Q S di di d ag ag agno o ost st stic c c sco c c re re e 12 2 2 wa as 7 7 c c con n nsis s ste en ent t t wi wi with th h hig g gh h pr r rob ob obabili i ity y y LQ Q QT T TS, he h her t t tre re ress ss ss t t tes es est t t wa a was s s at at atyp p ypic ic ical al al f f for or or L L LQT QT QTS S S wi i with th th ven en ent t tri ri ricu c cula la lar r r ec ec ecto to topy p py d d dur r urin in ing g g th th the e e st st stre re ress ss ss t t tes es est t t an an and d d th th thro ro roug g ugho ho hout t ut subsequent WES mutational results were filtered considering either a sporadic or autosomal recessive inheritance pattern (Figure 1 For our recessive model, we first limited the 116,276 variants to only include rare vari ian an ants ts ts w w wit it ith h h a fr fr freq eq equency 1% in the 1KG and N N NHL H H BI GO ESP databa ba ase se ses 10, 11 . This resulted in 1 1 15,7 7 726 variants. s s O Of th th thes es ese, e, e, a a a t t tot ot otal al al o o of f f 2, 2, 2,27 27 2 3 va va ari i iants s w w wer r re e e n no non-n-n-sy sy s no no nony ny nymo mo mous s. Fo o oll ll llow ow owin in ing g g in in inde de dex x x ca ca cas s sepa a are re ren nt n exome me me sub b ubt tr tract t tio on o /inc nc clu u usi s s on n n c c cri ite te teri r r a f f fitt t ting g g a a rece ce cess s iv iv ve e inh nh nher r rit tan a a ce c ce pat at atte e ern r r , th th he e ere we we ere 1 1 18 8 co co comp mp mpou o ound nd nd h h het et eter er eroz o ozyg g ygou o ous s s va a vari ri rian an ants ts ts i i in n n 9 9 9 ge ge gene ne nes s s an an and d d 5 5 5 au a auto to toso so soma ma mal l l ho ho homo mo mozygo go gous s us r r rec ec eces es essi si sive e ve var ar aria ia iant nt nts s s in in in 5 5 5 5 53_56 ACAG) resulting in a frame-shift mutation (p.D18fs*13) in the affected child (Figure 1 ).
Results
Whole Exome Sequencing (WES) and
Both unaffected parents were heterozygous for the mutation. Notably, 1 African American among the 1861 African American exomes of the NHLBI GO ESP was a D18fs*13 carrier (0.054% carrier frequency). D18fs*13 was absent in the NHLBI GO ESP Caucasian exomes and the 1KG 10, 11 . In addition, D18fs*13 was reported as a heterozygote variant in 7/61,085 (0.01%) individuals from the Exome Aggregation Consortium (ExAC) database overall and specifically, in 7 / 4986 (0.14%) individual African exomes 15 .
Spectrum and Prevalence of TRDN Mutations in a Cohort of Unrelated LQTS Patients
Subsequently, 33 unrelated phenotype-positive/genotype-negative patients ( Table 2 ) with a high probability diagnosis of LQTS (QTc 500 ms or a LQTS diagnostic score 3. 5 12 ) were analyzed for TRDN mutations. Of these 33 cases, 21 were female and 12 were male. The average age at diagnosis was 23.6 ± 18.7 years and ranged from 1 to 65 years. Nine patients were diagnosed at 10 years of age and 24 were diagnosed at > 10 years of age. The average QTc was 515 ± 56 ms. Forty-two percent of the patients had experienced syncope, 33% had cardiac arrest, and 36% had a positive family history of cardiac events. All 33 LQTS patients were mutation negative for all 16 LQTS-associated genes identified to date including (in alphabetical order), del 572_576 TAAGA) resulting in an immediate stop codon (p.K147fs*0). This mutation was absent in the NHLBI GO ESP, 1KG and ExAC databases 10, 11, 15 .
probability diagnosis of LQTS (QTc 500 ms or a LQTS diagnostic score 3. 5 12 2 ) ) ) we we were re re analyzed for TRDN mutations. Of these 33 cases, 21 were female and 12 were male Interestingly, all three patients displayed a phenotype very similar to the patient with the homozygous p.D18fs*13 mutation identified by WES. The homozygous p.K147fs*0 mutation was identified in a 2-year-old Indian female with a LQTS diagnostic score of 7.5 secondary to a QTc of 490 ms, evidence of torsades de pointes, personal history of syncope with stress, and a family history of unexplained cardiac death (Figure 2, Table 3 ). Electrocardiographically, she also exhibited persistent and extensive T-wave inversion in precordial leads V1 -V4 (Figure 3) .
She first experienced exercise-induced syncope at one year of age and then experienced SCA at 2 years of age. She received an ICD, underwent LCSD surgery, and was continued on betablocker therapy. Subsequently, she experienced syncope while swimming and during dance class.
At 6 years of age, she was noted to have slight proximal muscle weakness.
Despite her parents both being considered unaffected with a normal QTc, there is a family history of a paternal first degree cousin who experienced an unexplained sudden cardiac death (SCD) at the age of 6 years. Her parents' genomic DNA was analyzed, with both parents having the same heterozygous p.K147fs*0 mutation, indicating an autosomal recessive model of inheritance. Furthermore, her paternal uncle, the father of the 6 year-old cousin who experienced a SCD, was also found to be heterozygous for p.K147fs*0. DNA was unavailable for the deceased cousin and her mother.
The same homozygous p.K147fs*0 mutation was also identified in a 5-year-old Arabic male with a LQTS diagnostic score of 5.5 due to a QTc of 480 ms, personal history of syncope with stress, and a family history of unexplained cardiac arrest (Figure 2, Table 3 ). On ECG, he too had extensive T-wave inversion in precordial leads V1-V4 (Figure 3) . He experienced exercise-induced syncope at two years of age and his first cardiac arrest occurred at 2.5 years of age, followed by two more cardiac arrest events, which occurred within a month of one another.
Despite her parents both being considered unaffected with a normal QTc, there is a fami mi ily ly ly h h his is isto to tory ry ry of f f a a a paternal first degree cousin w w who ho ho experienced an unex ex expl p p ained sudden cardiac At age 3 years, he underwent videoscopic LCSD surgery, was implanted with an ICD, and was maintained on beta-blocker. Following this treatment strategy, he continued to experience several appropriate VF/VT-terminating ICD shocks. The patient's parents are consanguineous first degree cousins and are both phenotype-negative for LQTS. However, the patient's older sister experienced syncope and cardiac arrest at 2 years of age. DNA was unavailable for the unaffected parents and the affected sibling.
The third unrelated patient with this same homozygous K147fs*0 frame-shift mutation, was a 6-year-old Indian female with a LQTS diagnostic score of 7 ( Figure 2, Table 3 ). The family history was negative for cardiac events. The patient's parents, who are consanguineous second cousins and both phenotype-negative for LQTS, were each heterozygous for the K147fs*0 mutation. The patient experienced cardiac arrest at 23 months and was defibrillated twice on scene from reported VF. The patient exhibited transient QT prolongation (QTc > 500 ms) and telemetry captured brief runs of polymorphic-VT including bidirectional-VT. The latter arrhythmia prompted initial consideration of catecholaminergic polymorphic ventricular tachycardia (CPVT). Akin to the previous cases, her ECG consistently and persistently exhibits T-wave inversions in leads III and IV as well as the precordial leads of V1-V4 (Figure 3) .
Following her cardiac arrest, she was dismissed with a combination therapy of beta-blocker and ICD. She subsequently experienced 3 appropriate exertion-induced VF-terminating shocks from her ICD while on beta-blocker therapy. Ultimately, she underwent videoscopic LCSD surgery and dismissed on one-a-day (10 mg) nadolol. However, she experienced her fourth appropriate shock post-denervation and her nadolol dose was increased to 10 mg twice-a-day.
Finally, a 2-year-old Caucasian male patient diagnosed with LQTS following a cardiac arrest at age 20 months, was compound heterozygous with two putative pathogenic TRDN econd cousins and both phenotype-negative for LQTS, were each heterozygous fo fo for r r th th the e e K147fs*0 mutation. The patient experienced cardiac arrest at 23 months and was defibrillated . Ak Ak Akin in in t t to o o th th the e e pr pr prev e evio io ious s us c c cas as ases es es, he he her r r EC EC ECG G G co co cons ns nsis is iste te ten n ntl tl tly an an and d d pe pe pers rs rsis is iste te tent nt ntly l ly e e exh h xhib ib ibit it its s s mutations (Figure 2 , Table 3 ). The child had in utero bradycardia and ECGs documenting borderline QT-intervals. Following the child's sentinel event of cardiac arrest with documented VF at 20 months of age, he was diagnosed with possible LQTS. He was placed on beta-blocker and implanted with an ICD as secondary prevention. He remained event free for a year until he experienced his first appropriate VF-terminating single ICD shock during exertion.
Electrocardiographically, he presents with deeply inverted T-waves in the precordial leads V1-V4 and a QTc of 464 ms (Figure 3) . In addition, this child is now 4 years old and has begun exhibiting mild to moderate skeletal muscle weakness and decreased muscle tone.
This child was heterozygous for the same K147fs*0 frame-shift mutation (maternally derived) and heterozygous for a paternally inherited putative splicing error mutation (c.22+29
A>G). The parents are both phenotypically normal with a negative family history of cardiac events. According to ESE finder 16 , a publically available on-line splice-site prediction algorithm, the intron 1 wild-type donor splice-site c.22+1_2 (GCTGAAGgtattgctacc) registers a weak splice site score (5.01380) below the algorithm's default threshold of 6.67 for predicting a donor splice-site, suggesting that this exon/intron 1 may be susceptible to alternative splicing. In fact, ESE finder predicts the alternative GT site at c.22+30_31 (gtatcaagtaaggaaaa) actually has a higher score (6.18470) than the wild-type donor splice site, but still below the default threshold.
However, when altering the intronic nucleotide c.22+29 A to a G, the alternative GT site (gtatcaggtaaggaaaa) now scores a 9.57210, well above the 6.67 threshold score for predicting this donor splice site. This strongly suggests that the alternative donor site would be preferentially used over the wild-type site, thus resulting in the inclusion of 29 additional Herein, we identified TRDN-encoded triadin as a novel genetic basis for recessively inherited LQTS. In fact, nearly 15% of our overall and 50% of our childhood aged ( 10 years) genetically elusive LQTS cohort hosted homozygous/compound heterozygous TRDN frame-shift mutations. However since this is a small cohort, the prevalence may not be reflective of the general population of gene-negative LQTS. Since frame-shift mutations often result in nonfunctional proteins or immediate nonsense-mediated RNA decay, these patients are most likely triadin null.
TRDN is a gene expressed in both cardiac and skeletal muscle and undergoes extensive alternative splicing in order to produce several isoforms [21] [22] [23] . alternative splicing in order to produce several isoforms [21] [22] [23] . Cardiac triadin is a 2 2 286 86 86 a a ami mi mino no no a a aci ci cid ransmembrane protein with a short 47 amino acid N-terminal cytoplasmic region, amino acids 48-6 6 68 8 8 im im imbe be bedd dd dded d i i in n n the junctional sarcoplasmic re re reti ti tic c culum (jSR) membra ra an n ne, and a long positively ch ch char ar arged C-term m min in ina al t t tai ai ail ex ex exte te tend nd ndin in ing g g in in into to th he S S SR R R lum men n n 24 . . Furthermore, LQTS-causing calmodulin mutations disrupt calcium-dependent inactivation of the LTCC 25, 26 . Therefore, it is biologically plausible that a decrease in I Ca,L inactivation, caused by loss of triadin, could lead to prolonged cardiac action potential and a LQTS phenotype.
Interestingly, TRDN mutations have been implicated previously in recessively inherited CPVT being identified in 2/97 (2%) patients diagnosed with CPVT who were genotype-negative for RYR2 or CASQ2 mutations 27 . Specifically, a homozygous p.D18fs*13 mutation was identified in a 2-year-old boy who experienced exertion-induced syncope and cardiac arrest and compound heterozygous TRDN mutations (p.T59R and p.Q205X) were identified in a 26-yearold male who experienced recurrent exertion-induced syncope since infancy 27 . In both cases, their resting ECGs were stated to be normal with no QT-interval prolongation.
Curiously, we identified this precise TRDN homozygous p.D18fs*13 mutation in a LQTS patient with a QTc of 500 ms and p.K147fs*0 in 4 additional unrelated LQTS patients with QT prolongation. While our patients and the CPVT patients reported by Roux-Buission are phenotypically similar, our findings suggest that homozygous/compound heterozygous TRDN mutations may underlie malignant, autosomal recessive LQTS. We have examined 42 unrelated patients with genetically elusive CPVT/IVF and no TRDN mutations were identified (data not shown).
Remarkably, all five TRDN null patients displayed the common electrocardiographic phenotype of extensive T-wave inversions in precordial leads V1-V4, severe disease expression of exercise-induced cardiac arrest in early childhood ( 3 years of age), a recessive inheritance dentified in a 2-year-old boy who experienced exertion-induced syncope and card rd rdia ia iac c c ar ar arre re rest st st a a and n n compound heterozygous TRDN mutations (p.T59R and p.Q205X) were identified in a 26-yearold ma ma male le le w w who ho ho exp xp xpe e erienced recurrent exertion-ind d duc uc uced e e syncope since inf nf fan an ncy 27 . In both cases, h h hei i ir resting EC C CGs G Gs w w we er e e e e st st sta at ated ed ed t t to o be be be no no orm mal al l w w with no no o Q QT-T-T-i in inte te ter r rval al al p p pro ro rolo lo long ng n atio o on. n. n. Although all 5 cases with a strikingly similar phenotype host either homozygous (D18fs*13 or K147fs*0; 4 cases) or compound heterozygous (K147fs*0 and p.N9fs*5; 1 case)
TRDN frame-shift mutations that would result in early truncation of the triadin protein and presumably result in each patient being essentially TRDN null, we have not functionally characterized each specific mutation constituting a potential study limitation. While the creation and study of TRDN mutation specific mice or the use of patient specific induced pluripotent stem cell cardiomyocytes (iPS-CM) would be desirable, these studies are beyond the scope of this current manuscript. However, previous studies on TRDN null mice that were engineered through targeted removal of the first exon of the TRDN gene do provide substantial support in the proposed mechanism of disease phenotype observed in our TRDN null patients 14, 28 Based on the TRDN null mice observations, a LTCC channel blocker, like nifedipine or verapamil may be a therapeutic consideration for these patients 14 . Given these atypical LQTS phenotypic features that are in common among TRDN null patients, we propose that either triadin knockout (TKO) syndrome (Table 4) , or TRDN-mediated autosomal recessive LQTS should be used rather than LQT17. In fact, the mechanistic insights observed in the TRDN null D18fs*13 or K147fs*0; 4 cases) or compound heterozygous (K147fs*0 and p.N9f 9f 9fs* s* s*5; 5; 5; 1 1 1 c c cas as ase) e) e)
TRDN frame-shift mutations that would result in N early truncation of the triadin protein and pres sum um umab ab ably ly ly r r res e ul ul ult t t in i each patient being essential al lly ly ly T T TRDN null, we hav ve e e n n not functionally ch ch char ar aracterized d ea ea ach c ch spe pe peci i cifi fi fic c c mu mu muta ta tati ti tion on n c con on o st tit it itut ut uti ing a p p pot t ten en enti ti tial al a s s stu udy d d l l lim im imit it itat t tion n n. Wh Wh Whil il ile e e th h he e e cr r rea ea eati ti tio on on an n nd d d st st s udy of f f T T TRD D DN N N mu mu mut ta t tion on n s s spe pe peci i ifi fi fic mi m mice o o or r r the u u use of of of p pat at atie e ent n n s s sp pe peci ci c fic c i ind d duc uc uced e p p plu lu lur ripo ote e ent t t tem em em c c cel el ell l l ca ca card rd rdio io iomy m myoc oc ocyt t ytes es es ( ( (iP iP iPS S S-CM CM CM) ) ) wo o woul l uld d d be be be d d des es esi i ira ra rabl bl ble e e, t t the he hese se se s s stu t tudi di dies es es ar ar are e e be be beyo o yond nd nd t t the he he s s sco co cope pe pe o o of f f mice support this as a unique disorder 14 . Unlike the mechanism of SR Ca 2+ leak and triggered beats at normal or decreased SR Ca 2+ load observed with RYR2/CASQ2-mediated CPVT, loss of cardiac triadin dramatically reduces the negative feedback on the LTCC resulting in net increase in Ca 2+ influx into the cell leading to myocyte Ca 2+ overload, increases in SCR frequency, and VT, particularly in the setting of -adrenergic stimulation 14 .
While the prevalence of triadin truncating mutations in the general Middle Eastern or South Asian populations is not currently known, because 3/5 of our cases descended from these geographical regions and all were found to be homozygous for K147fs*0 mutation, we suspect the incidence of TKO syndrome could be even greater in this region of the world where consanguineous marriages may constitute 20-50% of all marriages 29 . Provided the potential devastating outcome of pediatric sudden cardiac death associated with TKO syndrome, the phenotypic and genotypic characterization of this newly described syndrome may have profound implications for premarital and preconception genetic counseling, especially in highly consanguineous populations.
With the identification of recessively inherited TRDN frame-shift mutations in early childhood LQTS patients manifesting with multiple episodes of exertion-induced syncope/cardiac arrest, a common electrocardiographic signature of extensive T-wave inversion in precordial leads V1-V4 with consistent or transient QT-prolongation, and the possibility of skeletal muscle weakness, we describe for the first time tridain knockout (TKO) syndrome.
Given the recurrent nature of potential lethal arrhythmias, patients fitting this phenotypic profile should undergo cardiac TRDN genetic testing.
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